Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Checkpoint Therapeutics Inc’s stock clocked out at $3.31, down -4.34% from its previous closing price of $3.46. In other words, the price has decreased by -$4.34 from its previous closing price. On the day, 0.73 million shares were traded. CKPT stock price reached its highest trading level at $3.39 during the session, while it also had its lowest trading level at $3.21.
Ratios:
To gain a deeper understanding of CKPT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on January 13, 2025, initiated with a Buy rating and assigned the stock a target price of $9.
On June 09, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $18.B. Riley Securities initiated its Buy rating on June 09, 2021, with a $18 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 10 ’25 when Oliviero James F III sold 10,331 shares for $3.15 per share. The transaction valued at 32,543 led to the insider holds 3,775,019 shares of the business.
Oliviero James F III sold 9,233 shares of CKPT for $31,485 on Feb 07 ’25. The CEO, President and Director now owns 3,785,350 shares after completing the transaction at $3.41 per share. On Feb 06 ’25, another insider, GRAY WILLIAM GARRETT, who serves as the Chief Financial Officer of the company, sold 74,110 shares for $3.67 each. As a result, the insider received 271,984 and left with 1,458,644 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CKPT now has a Market Capitalization of 161635568 and an Enterprise Value of 156932576. For the stock, the TTM Price-to-Sale (P/S) ratio is 3232.55. Its current Enterprise Value per Revenue stands at 3338.991.
Stock Price History:
The Beta on a monthly basis for CKPT is 1.42, which has changed by 0.67171717 over the last 52 weeks, in comparison to a change of 0.22894537 over the same period for the S&P500. Over the past 52 weeks, CKPT has reached a high of $4.50, while it has fallen to a 52-week low of $1.38. The 50-Day Moving Average of the stock is -2.99%, while the 200-Day Moving Average is calculated to be 23.13%.
Shares Statistics:
It appears that CKPT traded 1.37M shares on average per day over the past three months and 948470 shares per day over the past ten days. A total of 45.10M shares are outstanding, with a floating share count of 35.94M. Insiders hold about 26.43% of the company’s shares, while institutions hold 22.10% stake in the company. Shares short for CKPT as of 1738281600 were 7759078 with a Short Ratio of 5.65, compared to 1735603200 on 7996425. Therefore, it implies a Short% of Shares Outstanding of 7759078 and a Short% of Float of 17.080000000000002.
